Despite the absence of MHC class II molecules on tumor cells, stem-cell-like CD4(+) T cells specific for tumor neoantigens can enhance the antitumor effects by interacting with antigen-presenting cells and promoting antitumor CD8(+) T cells in the tumor microenvironment and draining lymph nodes.
Despite the absence of MHC class II molecules on tumor cells, stem-cell-like CD4(+) T cells specific for tumor neoantigens can mediate profound antitumor effects by licensing antigen-presenting cells and augmenting antitumor CD8(+) T cells in the tumor microenvironment and draining lymph nodes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据